BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 9, 2012
View Archived Issues
Combination studies of biapenem and RPX-7009 reported
Read More
Evolva synthesizes novel topoisomerase inhibitors
Read More
Novel anticancer oligopeptides patented by CSIR
Read More
Ludwig Institute for Cancer Research discloses novel TbetaR-I blocking antibodies
Read More
Kissei Pharmaceutical synthesizes new D2 receptor agonists
Read More
BARDA exercises contract option for Emergent's anthrax vaccine candidate
Read More
Janssen Biotech patents new antibodies targeting human TF
Read More
Cancer Research Technology develops novel TTK inhibitors
Read More
Evotec achieves preclinical milestone in drug discovery collaboration with Novartis
Read More
ImaginAb and Lundbeck to develop antibodies targeting CNS disorders
Read More
New valproic acid prodrugs designed at the University of Florida
Read More
TL-118 shows therapeutic potential in mouse model of liver metastases
Read More
Cempra reports results from phase I intravenous solithromycin study
Read More
Trevena reports initial results from phase IIa study of TRV-027
Read More
BioSante Pharmaceuticals and ANI Pharmaceuticals agree to merge
Read More
StemCells confirms first transplant of neural stem cells in macular degeneration study
Read More
Ferrer completes absorption, tolerability and safety study of novel antibacterial agent
Read More
arGEN-X out-licenses anti-IL-6 antibody
Read More
GlaxoSmithKline to return rights to GSK-2251052
Read More
Chiesi Farmaceutici to market LCP-Tacro in Europe, Turkey and CIS countries
Read More
Fibrocell Science raises funds, enters strategic collaboration with Intrexon
Read More
Patient dosing begins in phase II trial of Grifols' inhaled alpha1-proteinase inhibitor
Read More
Sangart completes enrollment in phase IIb trial of novel ischemic rescue therapy
Read More
Revance Therapeutics regains worldwide rights to botulinum toxin products
Read More
FDA approves the Dexcom G4 PLATINUM continuous glucose monitoring system
Read More